Dr Reddy’s Laboratories gets EIR for Srikakulam plant

By: |
February 27, 2018 2:01 AM

Without going into the content of the EIR, said the USFDA has maintained official action indicated status at its plant.

DRL, Dr Reddy's Laboratories, EIR, Srikakulam plantDr Reddy’s Laboratories has received the establishment inspection report (EIR) from the drug regulator USFDA for its Srikakulam plant. (Reuters)

Dr Reddy’s Laboratories has received the establishment inspection report (EIR) from the drug regulator USFDA for its Srikakulam plant. The drug regulator has sought more details post its inspection of the plant. Without going into the content of the EIR, said the USFDA has maintained official action indicated status at its plant. “The FDA has asked us for more details. We are providing those details and continuing to engage with the FDA for resolution of pending issues,” DRL said in a filing.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1I wish govt’s COVID vaccine strategy was ‘mann ki baat’: Rahul Gandhi
2Punjab govt appoints 8,000 nodal officers, to give more agri-machines to check stubble burning
3Pawar hails SAD for walking out of NDA over farm bills